News
Asahi Kasei Bioprocess has launched its official LinkedIn and WeChat accounts
Apr 01, 2022
As part of our marketing activities, Asahi Kasei Bioprocess opened new LinkedIn (English) and WeChat (Chinese) accounts.
By following these accounts, a range of timely information about the Asahi Kasei Bioprocess, such as press releases and events, can be obtained.
Asahi Kasei Medical aims to provide "Assurance Beyond Expectation" in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, scientific support, and biosafety testing services to help biologics manufacturers safely and efficiently produce medicines that patients can trust.
- Asahi Kasei Bioprocess' official LinkedIn account (English)
＠Asahi Kasei Bioprocess
https://www.linkedin.com/company/asahikaseibioprocess
- Asahi Kasei Bioprocess' official WeChat account (Chinese)
＠旭化成生物工艺
https://mp.weixin.qq.com/mp/profile_extaction=home&__biz=Mzg5ODY1NzEyMA==&scene=124#wechat_redirect
Open the WeChat app to access to the URL.
- Social Media Policy by Asahi Kasei Corp.
https://www.asahi-kasei.com/social_media/
- Please get in touch with us via the following inquiry form:
